CBPO [China Biologic Products] 6-K:
[]
EDU [New Oriental Education & Technology] 6-K: (Original Filing)
[New Oriental Announces Results for the Fourth Fiscal Quarter and Fiscal Year Ended May 31, 2018 Quarterly Net Revenues Increased by 44.1% Year-Over-Year Quarterly Student Enrollments Increased by 44.9% Year-Over-Year Fiscal Year Net Revenues Increased by 36% Year-Over-Year Fiscal Year Student Enroll]
SOL [ReneSola] 6-K: ReneSola Announces Notice of Annual General Meeting Shanghai,
[ReneSola Announces Notice of Annual General Meeting Shanghai, China, July 25, 2018 www.renesolapower.com http://ir.renesolapower.com Copies of the notice of the AGM, proxy form, poll card and annual report are available on ReneSola's investor relations website at AGM Resolutions The following resolu]
SGOC [SGOCO] F-1/A: (Original Filing)
[CALCULATION OF REGISTRATION FEE Title of Each Amount to be Proposed Proposed Amount of Subscription Rights to purchase ordinary shares, $0.004 par value per share — — — — (2) Ordinary shares, $0.004 par value per share, issuable upon exercise of Subscription Rights — — $ 50,000,000 (3) $ 6,225.00 To]
WBAI [500.com] 6-K: 500.com Limited to Report Second Quarter 2018 Financial
[500.com Limited to Report Second Quarter 2018 Financial Results on July 27, 2018 SHENZHEN, China, July 25, 2018—500.com Limited (NYSE: WBAI) (“500.com” or the “Company”), a leading online sports lottery service provider in China, today announced that it will release its financial results for the sec]
SGOC [SGOCO] F-1/A: CALCULATION OF REGISTRATION FEE Title of Each Amount
[CALCULATION OF REGISTRATION FEE Title of Each Amount to be Proposed Proposed Amount of Subscription Rights to purchase ordinary shares, $0.004 par value per share — — — — (2) Ordinary shares, $0.004 par value per share, issuable upon exercise of Subscription Rights — — $ 50,000,000 (3) $ 6,225.00 To]
BSPM [Biostar Pharmaceuticals] 8-K: Biostar Pharmaceuticals Received Nasdaq Delisting Notification XIANYANG, China,
[Biostar Pharmaceuticals Received Nasdaq Delisting Notification XIANYANG, China, July 25, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on July 19, 2018 it rece]
